ZYME
Zymeworks Inc
NASDAQ · Biotechnology
$22.72
+0.70 (+3.18%)
Open$22.38
Previous Close$22.02
Day High$23.06
Day Low$22.34
52W High$28.49
52W Low$9.03
Volume—
Avg Volume603.8K
Market Cap1.76B
P/E Ratio—
EPS$-0.84
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
-21.4% upside
Current
$22.72
$22.72
Target
$17.86
$17.86
$12.55
$17.86 avg
$20.90
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 77.93M | 54.92M | 202.10M |
| Net Income | -125,317,700 | -79,477,084 | 41.57M |
| Profit Margin | -160.8% | -152.8% | 20.6% |
| EBITDA | -135,984,850 | -91,033,477 | 55.44M |
| Free Cash Flow | — | — | 25.75M |
| Rev Growth | +41.9% | +41.9% | +14.0% |
| Debt/Equity | 0.00 | 0.00 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |